Dashboard
Manage Tickers

GTHX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

g1-therapeutics-reaffirms-fy24-cosela-revenue-of-60m-70m
G1 Therapeutics Reaffirms FY24 COSELA Reve...
08/08/2024 10:35:14

2024 Financial Guidance G1 today reaffirmed its full year 2024 revenue guidance. G1's guidance is based on current expecta...

g1-therapeutics-q2-2024-gaap-eps-010-beats-017-estimate-sales-16546m-beat-16363m-estimate
G1 Therapeutics Q2 2024 GAAP EPS $(0.10) B...
08/08/2024 10:33:34

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.1...

needham-downgrades-g1-therapeutics-to-hold
Needham Downgrades G1 Therapeutics to Hold
08/07/2024 20:09:38

Needham analyst Gil Blum downgrades G1 Therapeutics (NASDAQ:GTHX) from Buy to Hold.

dow-tumbles-over-200-points-cvs-health-cuts-profit-forecast
Dow Tumbles Over 200 Points; CVS Health Cu...
08/07/2024 18:38:50

crude-oil-jumps-over-3-upstart-shares-spike-higher
Crude Oil Jumps Over 3%; Upstart Shares Sp...
08/07/2024 16:03:23

nasdaq-jumps-250-points-disney-earnings-beat-estimates
Nasdaq Jumps 250 Points; Disney Earnings B...
08/07/2024 14:38:26

pharmacosmos-group-to-acquire-g1-therapeutics-g1s-shareholders-to-receive-715-per-share-in-cash-for-a-total-equity-value-of-approximately-405m
Pharmacosmos Group To Acquire G1 Therapeut...
08/07/2024 10:35:10

g1-therapeutics-added-to-russell-2000-and-3000-indexes-effective-at-open-jul-1
G1 Therapeutics Added To Russell 2000 And ...
07/01/2024 12:11:50

hc-wainwright--co-maintains-buy-on-g1-therapeutics-lowers-price-target-to-3
HC Wainwright & Co. Maintains Buy on G1 Th...
06/25/2024 11:28:11

HC Wainwright & Co. analyst Edward White maintains G1 Therapeutics (NASDAQ:GTHX) with a Buy and lowers the price target ...

ball-to-rally-more-than-23-here-are-10-top-analyst-forecasts-for-tuesday
Ball To Rally More Than 23%? Here Are 10 T...
06/25/2024 11:27:06

needham-maintains-buy-on-g1-therapeutics-lowers-price-target-to-6
Needham Maintains Buy on G1 Therapeutics, ...
06/25/2024 10:10:41

Needham analyst Gil Blum maintains G1 Therapeutics (NASDAQ:GTHX) with a Buy and lowers the price target from $12 to $6.

alnylams-closely-watched-phase-3-heart-disease-trial-of-vutrisiran-hits-primary-endpoint-shares-surge
Alnylam's Closely Watched Phase 3 Heart Di...
06/24/2024 13:49:11

Alnylam Pharmaceuticals reports positive results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardio...

why-is-cancer-focused-g1-therapeutics-stock-trading-lower-on-monday
Why Is Cancer-Focused G1 Therapeutics Stoc...
06/24/2024 13:40:08

Shares of G1 Therapeutics are down after release of Phase 3 trial results for trilaciclib in TNBC.

g1-therapeutics-preserve-2-phase-3-trial-of-trilaciclib-before-first-line-chemotherapy-in-metastatic-triple-negative-breast-cancer-did-not-achieve-statistical-significance-in-primary-endpoint-of-overall-survival
G1 Therapeutics' PRESERVE 2 Phase 3 Trial ...
06/24/2024 10:34:36

The Company Will Focus its Efforts on the Global Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Market. G1 is Sufficiently...

analyst-ratings-for-g1-therapeutics
Analyst Ratings For G1 Therapeutics
06/13/2024 12:00:56

needham-reiterates-buy-on-g1-therapeutics-maintains-12-price-target
Needham Reiterates Buy on G1 Therapeutics,...
06/13/2024 09:31:08

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/11/2024 17:35:23

why-applied-dna-sciences-shares-are-trading-lower-by-around-68-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Applied DNA Sciences Shares Are Tradin...
05/28/2024 17:24:16

hc-wainwright--co-reiterates-buy-on-g1-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on G1 T...
05/28/2024 16:32:53

HC Wainwright & Co. analyst Edward White reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $9 price target.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/28/2024 16:31:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION